Pyridoxal-5-phosphate and stent for the treatment and prevention of atherosclerosis and restenosis

Details for Australian Patent Application No. 2005309352 (hide)

Owner Medicure International Inc.

Inventors Zettler, Marjorie

Agent Griffith Hack

Pub. Number AU-A-2005309352

PCT Pub. Number WO2006/056038

Priority 60/612,710 24.09.04 US

Filing date 26 September 2005

Wipo publication date 1 June 2006

International Classifications

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61L 27/40 (2006.01) Materials for prostheses or for coating prostheses

A61L 27/54 (2006.01) Materials for prostheses or for coating prostheses

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

5 April 2007 PCT application entered the National Phase

  PCT publication WO2006/056038 Priority application(s): WO2006/056038

10 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005309364-Graphical user interface for tissue biopsy system

2005309347-Refined sugar manufacturing through process